Focusing on the field of precision medicine, the two parties will engage in comprehensive cooperation based on overall solutions including nucleic acid extraction, high-throughput sequencing, and PCR testing to jointly promote the development and application in fields such as infection and oncology, empowering the clinical transformation of scientific research achievements.
Dymind Biotech and Shenzhen Unicom reached strategic cooperation to jointly build a new ecosystem of smart healthcare
On September 22, Dymind Biotechnolgoy Co., Ltd. announced that it had recently signed a strategic cooperation agreement with the Shenzhen Branch of China Unicom, working together to explore innovative practices in the field of smart healthcare.
The two parties will cooperate to promote the integration of digital technology and in vitro diagnosis, to assist medical institutions to optimize the whole process management of samples, to compress the time before, during and after the flow of test samples, to improve the efficiency of hospitals, and to make full use of Unicom's innovative application capabilities of AI big data, to carry out AI research on test big data in the laboratory department and multicenter research work. At the same time, the two sides plan to build a medical industry AI and big data application base.
Igenesis joined hand with Denmark¡¯s PentaBase to cooperate on molecular diagnostic and POCT solutions
On September 20, Igenesis (Shanghai) Co., Ltd. and PentaBase A/S of Denmark announced a strategic cooperation. The two parties will work together to develop and promote advanced molecular diagnostic solutions, and strengthen deep cooperation in product research, production, marketing and sales.
Waters and Metware reached a strategic cooperation for innovating and developing precision medicine
On September 19, Waters Technologies (Shanghai) Ltd. and Metware Biotechnology Inc announced a formal strategic cooperation, further deepening the comprehensive cooperation between the two parties in multiple fields such as clinical diagnosis and multi omics research, biomarker discovery, scientific research services and instrument platform construction, clinical diagnostic reagent research and development and transformation, and jointly supporting precision medical innovation research and development.
